Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Aaronson, 2002, A road map for those who don’t know JAK-STAT, Science, 296, 1653, 10.1126/science.1071545

Atefi, 2014, Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma, Clin. Cancer Res., 20, 3446, 10.1158/1078-0432.CCR-13-2797

Chen, 1999, Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression, Mol. Cell. Biol., 19, 4695, 10.1128/MCB.19.7.4695

Darnell, 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 10.1126/science.8197455

Decker, 1991, Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor, EMBO J., 10, 927, 10.1002/j.1460-2075.1991.tb08026.x

Domanski, 1996, The type-I interferon receptor. The long and short of it, Cytokine Growth Factor Rev., 7, 143, 10.1016/1359-6101(96)00017-2

Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat. Med., 8, 793, 10.1038/nm730

Dunn, 2005, IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression, Cancer Res., 65, 3447, 10.1158/0008-5472.CAN-04-4316

Escuin-Ordinas, 2014, COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors, Mol. Oncol., 8, 250, 10.1016/j.molonc.2013.11.005

Friedman, 1985, α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences, Nature, 314, 637, 10.1038/314637a0

Gao, 2016, Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy, Cell, 167, 397, 10.1016/j.cell.2016.08.069

Herbst, 2014, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients, Nature, 515, 563, 10.1038/nature14011

Isaacs, 1957, Virus interference. I. The interferon, Proc. R. Soc. Lond. B Biol. Sci., 147, 258, 10.1098/rspb.1957.0048

Ivashkiv, 2014, Regulation of type I interferon responses, Nat. Rev. Immunol., 14, 36, 10.1038/nri3581

Kaplan, 1998, Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad. Sci. USA, 95, 7556, 10.1073/pnas.95.13.7556

Kappes, 2001, Safety considerations in vector development, Somat. Cell Mol. Genet., 26, 147, 10.1023/A:1021082815013

Kessler, 1988, Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes, Proc. Natl. Acad. Sci. USA, 85, 8521, 10.1073/pnas.85.22.8521

Kim, 2005, Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells, Am. J. Respir. Cell Mol. Biol., 33, 280, 10.1165/rcmb.2004-0129OC

Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36

König, 2007, A probability-based approach for the analysis of large-scale RNAi screens, Nat. Methods, 4, 847, 10.1038/nmeth1089

Kutmon, 2015, PathVisio 3: an extendable pathway analysis toolbox, PLoS Comput. Biol., 11, e1004085, 10.1371/journal.pcbi.1004085

Kutmon, 2016, WikiPathways: capturing the full diversity of pathway knowledge, Nucleic Acids Res., 44, D488, 10.1093/nar/gkv1024

Lee, 2006, Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274), FEBS Lett., 580, 755, 10.1016/j.febslet.2005.12.093

Lew, 1991, Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons, Mol. Cell. Biol., 11, 182

Loke, 2003, PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells, Proc. Natl. Acad. Sci. USA, 100, 5336, 10.1073/pnas.0931259100

Marzec, 2008, Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1), Proc. Natl. Acad. Sci. USA, 105, 20852, 10.1073/pnas.0810958105

Novick, 1994, The human interferon α/β receptor: characterization and molecular cloning, Cell, 77, 391, 10.1016/0092-8674(94)90154-6

Pachkov, 2007, SwissRegulon: a database of genome-wide annotations of regulatory sites, Nucleic Acids Res., 35, D127, 10.1093/nar/gkl857

Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat. Rev. Cancer, 12, 252, 10.1038/nrc3239

Platanias, 2005, Mechanisms of type-I- and type-II-interferon-mediated signalling, Nat. Rev. Immunol., 5, 375, 10.1038/nri1604

Platanias, 1999, CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors, Exp. Hematol., 27, 1315, 10.1016/S0301-472X(99)00060-0

Qing, 2004, Alternative activation of STAT1 and STAT3 in response to interferon-γ, J. Biol. Chem., 279, 41679, 10.1074/jbc.M406413200

Ribas, 2015, Adaptive immune resistance: how cancer protects from immune attack, Cancer Discov., 5, 915, 10.1158/2159-8290.CD-15-0563

Saha, 2010, Gene modulation and immunoregulatory roles of interferon γ, Cytokine, 50, 1, 10.1016/j.cyto.2009.11.021

Sambrook, 1989

Schroder, 2004, Interferon-γ: an overview of signals, mechanisms and functions, J. Leukoc. Biol., 75, 163, 10.1189/jlb.0603252

Shin, 2015, Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure, J. Immunother. Cancer, 3, 311, 10.1186/2051-1426-3-S2-P311

Shin, 2017, Primary resistance to PD-1 blockade mediated by JAK1/2 mutations, Cancer Discov., 7, 188, 10.1158/2159-8290.CD-16-1223

Silva, 2005, Second-generation shRNA libraries covering the mouse and human genomes, Nat. Genet., 37, 1281, 10.1038/ng1650

Smith, 2005, Type I interferons and the innate immune response--more than just antiviral cytokines, Mol. Immunol., 42, 869, 10.1016/j.molimm.2004.11.008

Sriuranpong, 2003, Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system, Cancer Res., 63, 2948

Stefan, 2011, Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon α-modulated mechanism, J. Biol. Chem., 286, 31168, 10.1074/jbc.M111.247510

Stump, 2011, A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis, Arthritis Res. Ther., 13, R68, 10.1186/ar3329

Tseng, 2001, B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells, J. Exp. Med., 193, 839, 10.1084/jem.193.7.839

Tumeh, 2014, PD-1 blockade induces responses by inhibiting adaptive immune resistance, Nature, 515, 568, 10.1038/nature13954

Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol., 3, H0034, 10.1186/gb-2002-3-7-research0034

Velazquez, 1992, A protein tyrosine kinase in the interferon α/β signaling pathway, Cell, 70, 313, 10.1016/0092-8674(92)90105-L

Zaretsky, 2016, Mutations associated with acquired resistance to PD-1 blockade in melanoma, N. Engl. J. Med., 375, 819, 10.1056/NEJMoa1604958